“Idiopathic sudden sensorineural hearing loss (ISSHL) is the newest indication approved by the Undersea and Hyperbaric Medical Society’s Hyperbaric Oxygen Therapy Committee” Sound research combined with clinical efficacy has bolstered the use of hyperbaric oxygen therapy for this condition. It gives us new hope in the hyperbaric industry that more conditions can follow and get recognized for the many indications that have been shown in recent literature, combined with the results seen in many of the private hyperbaric centers throughout the world <view study>